BlackRock Fund Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $145K | Buy |
8,475
+239
| +3% | +$4.09K | ﹤0.01% | 3513 |
|
|
2016
Q3 | $248K | Sell |
8,236
-11
| -0.1% | -$331 | ﹤0.01% | 3380 |
|
|
2016
Q2 | $233K | Buy |
8,247
+795
| +11% | +$22.5K | ﹤0.01% | 3405 |
|
|
2016
Q1 | $200K | Sell |
7,452
-544
| -7% | -$14.6K | ﹤0.01% | 3465 |
|
|
2015
Q4 | $385K | Buy |
7,996
+293
| +4% | +$14.1K | ﹤0.01% | 3322 |
|
|
2015
Q3 | $281K | Sell |
7,703
-203
| -3% | -$7.41K | ﹤0.01% | 3363 |
|
|
2015
Q2 | $298K | Sell |
7,906
-755
| -9% | -$28.5K | ﹤0.01% | 3372 |
|
|
2015
Q1 | $342K | Sell |
8,661
-587
| -6% | -$23.2K | ﹤0.01% | 3343 |
|
|
2014
Q4 | $380K | Buy |
9,248
+945
| +11% | +$38.8K | ﹤0.01% | 3317 |
|
|
2014
Q3 | $367K | Sell |
8,303
-603
| -7% | -$26.7K | ﹤0.01% | 3280 |
|
|
2014
Q2 | $387K | Buy |
8,906
+254
| +3% | +$11K | ﹤0.01% | 3261 |
|
|
2014
Q1 | $355K | Buy |
8,652
+1,049
| +14% | +$43K | ﹤0.01% | 3311 |
|
|
2013
Q4 | $302K | Buy |
7,603
+318
| +4% | +$12.6K | ﹤0.01% | 3316 |
|
|
2013
Q3 | $299K | Buy |
7,285
+1,690
| +30% | +$69.4K | ﹤0.01% | 3272 |
|
|
2013
Q2 | $217K | Buy |
+5,595
| New | +$217K | ﹤0.01% | 3295 |
|